Euronoxx Medical Group

The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization (WHO), recently unveiled the latest evaluations of the global burden of cancer. These estimates are based on a comprehensive encyclopedic overview of the world's countries in 2022. They shed light on the escalating challenge posed by cancer, particularly highlighting its inequitable impact on vulnerable populations. Globally cancer remains a formidable adversary, the figures from 2022 highlighting a stark picture. It is counted that there were 20 million recent cases of cancer and 9.7 million cancer-related deaths. The statistics further reveal that 53.5 million individuals were living within five years of a cancer diagnosis, indicating the enduring impact and survivorship journey that comes with combating cancer. One alarming statistic that stands out is that approximately 1 in 7 in the UK population will confront a breast cancer diagnosis in their lifetime. The burden of br...

Breast cancer continues to pose a significant global health challenge, with 2021 marking a diagnostic manoeuvre as it surpassed lung cancer to become the most frequently diagnosed cancer worldwide, particularly impacting women. Faced with this hindrance, effective breast cancer screening has emerged as a crucial tool in early detection, ultimately leading to improved patient outcomes. Breast Cancer Screening : Clinical Decision-Making! The implementation of population-based breast cancer screening programs in developed countries has played a vital role in reducing mortality rates and instances of advanced cancer. As a result, the need for comprehensive breast cancer screening guidelines has become increasingly apparent, providing clinicians with valuable resources for informed decision-making based on thorough evidence-based reviews and recommendations. Several developed countries have issued their own breast cancer screening guidelines, each accommodating their resp...